Panel of antibodies developed at Mount Sinai will enable first multiplexed potency assay for tracking neuraminidase in flu vaccines.
Gladstone scientists uncovered a possible strategy to "shock and kill" the virus that hides in cells
Pulse Center for Patient Safety Education & Advocacy can offer $10 "People's Price" to attend symposium — while seats last.
Grant Funding Will Support Preclinical Development of Two Vaccines Using Vaxess's MIMIX™ Delivery Platform
Pulse CPSEA extends $10 "People's Price" for community members — while seats last.
Same Day Results for 14 of the Most Common Causes of Infectious Diarrhea.
Seattle Biotech SpringStar awarded NIH Small Business Innovative Research Grant to commercialize groundbreaking trap for Zika carrying mosquitoes
New Patented technology now offers Healthcare workers the ability to treat and retreat their clothes with Residual Hydrogen Peroxide (RHP) in order to reduce cross-contamination risk from healthcare work clothes. RHP is an eco-friendly and effective way to reduce the bio-burden in your personal space. Once garments are treated, RHP remains effective for 20 launderings against MRSA and other dangerous pathogens. MRSA can live up to 56 days on clothing.
Thanks to initial $30,000 grants from The Campbell Foundation, three South Florida researchers have been able to go on to receive additional funding needed to move forward with their HIV/AIDS research.
OMICS International Conferences invites all the participants from all over the world to attend 'Infectious Diseases Europe 2016' which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions.
The global therapeutics and prophylactics market for Clostridium difficile infections (CDIs) will expand more than fourfold from $356.3 million in 2014 to over $1.5 billion by 2024, representing an impressive Compound Annual Growth Rate (CAGR) of 15.8%, according to research and consulting firm GlobalData's report by MarketinfoResearch.com
The recent outbreaks of Zika and dengue mean that it's all hands on deck at SpringStar, a Seattle biotech firm which manufactures the Trap-N-Kill mosquito trap.